HOS vs NUVB Comparison

Hornbeck Offshore Services Inc, through its subsidiaries, operates offshore supply vessels (OSVs), multi-purpose support vessels (MPSVs), and a shore-base facility. It provides marine transportation, logistics support, and related services to customers in the offshore oil and gas industry, in the U.S. Gulf Coast region, Latin America, and other international markets. The company also serves non-oilfield markets, including military support services, renewable energy projects, and other marine service activities. The majority of revenue is derived from the provision of vessel management services to external vessel owners and from providing shore-based port facility services.

Nuvation Bio Inc is a biopharmaceutical company tackling unmet needs in oncology by developing differentiated and novel therapeutic candidates. Its product candidate, taletrectinib, is an oral, potent, central nervous system-active, selective, next-generation c-ros oncogene 1 (ROS1) inhibitor designed for the treatment of patients with ROS1+ non-small cell lung cancer (NSCLC). In addition, its clinical-stage pipeline includes oncology product candidates such as Safusidenib, NUV-1511, and NUV-868 in different stages of development. The Company generates revenue from out-licensing collaborative agreements, including product revenue, upfront license fees, royalty revenue, and research and development services revenue. The Company generates the majority of its revenue from Japan.